Streetbeat News

Regulatory

OCGN

Ocugen, Inc. (NASDAQ:OCGN) shares rose after announcing approval to proceed with medium dose dosing in the Phase 1/2 study of OCU410. The Data and Safety Monitoring Board for the ArMaDa clinical trial approved this next step, highlighting the therapy's safety and potential as a one-time treatment for life. Ocugen also updated on progress in its gene therapy programs for blindness diseases. The company's stock is up 20%, trading at $1.81.

Portfolio Pulse from Erica Kollmann

April 05, 2024 | 7:56 pm

SPY

President Biden has committed his administration to ensuring that those responsible for the Baltimore Bridge collapse will bear the costs of repairing the damage. This statement underscores the government's stance on accountability for infrastructure failures.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 7:34 pm

AZN

The FDA has granted accelerated approval to ENHERTU, a treatment for unresectable or metastatic HER2-positive solid tumors. This decision could significantly impact the drug's availability and use in treating various cancers, marking a pivotal development for patients with these conditions.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 7:30 pm

DJT

Trump Media & Technology Group's shares are trading lower following its Nasdaq debut, amid calls by Democrats for an inquiry into alleged influence peddling.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 6:31 pm

FQVLF

GOLD

Zambia aims to increase its copper production to 1 million tons by 2026, leveraging the revival of Konkola Copper Mines and investments in existing mines like First Quantum Minerals' Kansanshi and Barrick's Lumwana. The emergence of KoBold Metals' AI-powered Mingomba project, potentially one of the world's largest mines, further boosts this goal. Despite facing debt restructuring challenges, Zambia remains optimistic about reaching its copper production targets.

Portfolio Pulse from Stjepan Kalinic

April 05, 2024 | 6:28 pm

META

Meta Platforms has filed a motion for summary judgment in the FTC lawsuit concerning its acquisitions of Instagram and WhatsApp, asking the court to dismiss the case due to lack of evidence supporting the FTC's antitrust claims.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 6:13 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo for April 5th, 2024, provides trading strategies for SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA based on proprietary formulas. It outlines potential price movements and advises traders to monitor these stocks for breakouts or reversals. The memo also highlights the importance of the upcoming Non-Farm Payroll numbers, Unemployment Rate, Average Hourly Earnings data, and Federal Reserve speakers' remarks, suggesting these could significantly impact market dynamics.

Portfolio Pulse from RIPS

April 05, 2024 | 6:09 pm

SPY

The Biden Administration is developing a preliminary climate model for Sustainable Aviation Fuel (SAF) subsidies, which will be more restrictive for ethanol producers than anticipated. Ethanol will not automatically qualify as an SAF feedstock under this model unless it is produced from corn that utilizes one of three specific sustainable agriculture techniques. The model may be expanded later in the year.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 6:07 pm

BMY

TSVT

The FDA approved Bristol-Myers Squibb (BMY) and 2seventy Bio Inc's (TSVT) Abecma for earlier use in pretreated blood cancer patients, expanding its indication. The approval, based on the KarMMa-3 trial, shows Abecma extends progression-free survival in patients with relapsed or refractory multiple myeloma. The FDA also updated Abecma's boxed warning to include secondary cancer risks.

Portfolio Pulse from Vandana Singh

April 05, 2024 | 5:37 pm

GLD

SPY

Fed's Bowman stated that the Federal Reserve is aware of gold's market movements but does not prioritize it over other commodities. This statement suggests a neutral stance towards gold in the Fed's monetary policy considerations.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 5:35 pm